Brain delivery of vasoactive intestinal peptide (VIP) following nasal administration to rats
- 22 February 2003
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 255 (1-2) , 87-97
- https://doi.org/10.1016/s0378-5173(03)00039-5
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Nasal Route for Direct Delivery of Solutes to the Central Nervous System: Fact or Fiction?Journal of Drug Targeting, 1998
- Delivery of125I-NGF to the Brain via the Olfactory RouteDrug Delivery, 1997
- In vivo dynamical distribution of 131I-VIP in the rat studied by gamma-cameraNuclear Medicine and Biology, 1994
- Partitioning of vasoactive intestinal polypeptide into lipid bilayersBiochimica et Biophysica Acta (BBA) - Biomembranes, 1994
- Vasoactive intestinal peptide encapsulated in liposomes: Effects on systemic arterial blood pressureLife Sciences, 1994
- The Transport of a Drug to the Cerebrospinal Fluid Directly from the Nasal Cavity: The Relation to the Lipophilicity of the Drug.CHEMICAL & PHARMACEUTICAL BULLETIN, 1991
- Distribution and Pharmacology of Vasoactive Intestinal Peptide Receptors in the Brain and PituitaryAnnals of the New York Academy of Sciences, 1988
- Absorption of drugs from the nasal mucosa of ratInternational Journal of Pharmaceutics, 1981
- Vasoactive intestinal peptide in man: pharmacokinetics, metabolic and circulatory effects.Gut, 1978
- Polypeptide with Broad Biological Activity: Isolation from Small IntestineScience, 1970